p53 mutations in hepatocellular carcinoma related to oral contraceptive use

Carcinogenesis

Volumn 17, Issue 1, 1996, Pages 145-149

  De Benedetti, Virna M G ^a   Welsh, Judith A ^a   Yu, Mimi C ^b   Bennett, William P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HYDROXYL RADICAL; ORAL CONTRACEPTIVE AGENT; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; ESTROGEN METABOLISM; FEMALE; GENE DELETION; GENE MUTATION; HEPATITIS B; HEPATITIS C; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NUCLEIC ACID BASE SUBSTITUTION; ORAL DRUG ADMINISTRATION; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BIOLOGY; CANCER; CONTRACEPTION; CONTRACEPTIVE METHODS; DISEASES; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GENETICS; HEPATIC EFFECTS; HISTOLOGY; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; NEOPLASMS; ORAL CONTRACEPTIVES; PHYSIOLOGY; RESEARCH REPORT;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; GENES, P53; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 0029878849     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.1.145     Document Type: Article

References (43)

1. Scott,L.D., Katz,A.R., Duke,J.H., Cowan,D.F. and Maklad,N.F. (1984) Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. J. Am. Med. Assoc., 251, 1461-1463.
2. Edmondson,H.A., Henderson,B. and Benton,B. (1976) Liver-cell adenomas associated with use of oral contraceptives. New Engl. J. Med., 294, 470-472.
3. Rooks,J.B., Ory,H.W., Ishak,K.G., Strauss,L.T., Greenspan.J.R., Hill,A.P. and Tyler,C.W.Jr (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. J. Am. Med. Assoc., 242, 644-648.
4. Yu,M.C., Tong,M.J., Govindarajan,S. and Henderson,B.E. (1991) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J. Natl Cancer Inst., 83, 1820-1826.
5. Forman,D., Vincent,T.J. and Doll,R. (1986) Cancer of the liver and the use of oral contraceptives. Br. Med. J. (Clin. Res. Edn), 292, 1357-1361.
6. Neuberger,J., Forman,D., Doll,R. and Williams,R. (1986) Oral contraceptives and hepatocellular carcinoma. Br. Med. J. (Clin. Res. Edn), 292, 1355-1357.
7. Watanabe,S. and Kobayashi,Y. (1993) Exogenous hormones and human cancer. Jpn J. Clin. Oncol., 23, 1-13.
8. Prentice,R.L. (1991) Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers. Preventive Med., 20, 38-46.
9. 9.IARC (1979) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 21, Sex Hormones (II). International Agency for Research on Cancer, Lyon, France.
10. Taper,H.S. (1978) The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats. Cancer, 42, 462-467.
11. Yager,J.D., Campbell,H.A., Longnecker,D.S., Roebuck,B.D. and Benoit, M.C. (1984) Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol. Cancer Res., 44, 3862-3869.
12. Yager,J.D. and Yager,R. (1980) Oral contraceptive steroids as promoters of hepatocarinogenesis in female Sprasue-Dawley rats. Cancer Res., 40, 3680-3685.
13. Henderson,B.E., Ross,R.K., Pike,M.C. and Casagrande,J.T. (1982) Endogenous hormones as a major factor in human cancer. Cancer Res., 42, 3232-3239.
14. Preston-Martin,S., Pike,M.C., Ross,R.K., Jones,P.A. and Henderson,B.E. (1990) Increased cell division as a cause of human cancer. Cancer Res., 50, 7415-7421.
15. Henderson,B.E., Ross,R. and Bernstein,L. (1988) Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res., 48, 246-253.
16. Harris,C.C. (1994) Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol. Biomarkers Prevention, 3, 1-2.
17. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 55, 4855-4878.
18. Jones,P.A., Buckley,J.D., Henderson,B.E, Ross,R.K. and Pike,M.C. (1991) From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res., 51, 3617-3620.
19. Bressac,B., Kew,M., Wands,J. and Ozturk,M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature, 350, 429-431.
20. Hsu,I.C., Metcalf,R.A., Sun,T., Welsh,J.A., Wang,N.J. and Harris,C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-428.
21. Hollstein,M., Sidransky,D., Vogelstein,B. and Harris,C.C. (1991) p53 mutations in human cancer. Science. 253, 49-53.
22. Takeshima,Y., Seyama,T., Bennett,W.P., Akiyama,M., Tokuoka,S., Inai,K., Mabuchi,K., Land,C.E. and Harris,C.C. (1993) p53 Mutations in lung cancers from non-smokine atomic-bomb survivors. Lancet, 342, 1520-1521.
23. Brash,D.E., Rudolph,J.A., Simon,J.A., Lin,A., McKenna,G.J., Baden,H.P., Halperin,A.J. and Pontën,J. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
24. Hollstein,M., Marion,M.J., Lehman,T., Welsh,J., Harris,C.C., Martel-Planche,G., Kusters,I. and Montesano,R. (1994) p53 Mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis, 15, 1-3.
25. DeBenedetti,V.M.G., Welsh,J.A.. Trivers,G.E., Harpster,A., Parkinson,A.J., Lanier,A.P., McMahon,B.J. and Bennett,W.P. (1995) p53 Alterations in hepatocellular carcinomas from Alaska Natives. Cancer Epidemiol. Biomarkers Prevention, 4. 79-82.
26. Sanger,F., Nicklen,S. and Coulson,A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA. 74, 5463-5467.
27. Weston,A., Perrin.,L.S., Forrester,K., Hoover,R.N., Trump,B.F., Harris,C.C. and Caporaso,N.E. (1992) Allelic frequency of a p53 polymorhism in human lung cancer. Cancer Epidemiol. Biomarkers Prevention. 1,481-483.
28. Lazar,V., Hazard,F., Bertin,F., Janin,N., Bellet,D. and Bressac,B. (1993) Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-1705.
29. Bennett,W.P., Hollstein,M.C., He,A. et al (1991) Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6, 1779-1784.
30. Matlashewski,G.J., Tuck,S., Pim,D., Lamb,P., Schneider,J. and Crawford,L.V. (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7, 961-963.
31. Henderson,B.E., Ross,R.K. and Pike,M.C. (1993) Hormonal chemoprevention of cancer in women. Science. 259, 633-638.
32. Liehr,J.G. and Roy,D. (1990) Free radical generation by redox cycling of estrogens. Free Radical Biol Med., 8, 415-423.
33. Rosier,J.A. and Van Peteghem,C.H. (1989) Peroxidative in vitro metabolism of diethylstilbestrol induces formation of 8-hydroxy-2′-deoxyguanosine. Carcinogenesis, 10, 405-406.
34. Han,X. and Liehr,J.G. (1994) 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res., 54, 5515-5517.
35. Gambrell,R.D.Jr. (1988) Hormonal medication and mitogenic dangers. In Stoll.B.A. (ed.). Endocrine Management of Cancer, vol. 2. Contemporary-Therapy. Karger, New York, NY, pp. 126-143.
36. Feig,D.I., Reid,T.M. and Loeb,L.A. (1994) Reactive oxygen species in tumorigenesis. Cancer Res., 54, 1890s-1894s.
37. Reid,T.M. and Loeb,L.A. (1992) Mutagenic specificity of oxygen radicals produced by human leukemia cells. Cancer Res., 52. 1082-1086.
38. Floyd,R.A. (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J.. 4. 2587-2597.
39. Grollman,A-P. and Moriya,M. (1993) Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet., 9, 246-249.
40. Lane,D.P. (1994) On the expression of the p53 protein in human cancer. Mol. Biol. Rep., 19, 23-29.
41. Hall,P.A. and Lane,D.P. (1994) p53 in tumour pathology: can we trust immunohistochemistry? - Revisited. J. Pathol., 172, 1-4.
42. Lane,D.P. (1994) The regulation of p53 function: Steiner Award Lecture. Int. J. Cancer, 57, 623-627.
43. Guinee, D.G.,Jr, Travis,W.D., Trivers,G.E. et al. (1995) Gender comparisons in human lung cancer: analysis of p53 mutations, serum antibodies and c-erbB-2 expression. Carcinogenesis, 16, 993-1002.